Ticker Scorecard - AXDX Basics Company: Accelerate Diagnostics, Inc. IPO Date: May 1, 1994 Sector: Healthcare Industry: Health Care Equipment and Supplies Market Cap: $26.8M Activated in VL: True Average Daily Range Avg Daily Range: $0.36 | 3.26% Avg Daily Range (30 D): $0.05 | 4.06% Avg Daily Range (90 D): $0.06 | 3.55% Institutional Daily Volume Avg Daily Volume: .03M Avg Daily Volume (30 D): .06M Avg Daily Volume (90 D): .05M Trade Size Avg Trade Size (Sh.): 17 Avg Trade Size (Sh.) (30 D): 246 Avg Trade Size (Sh.) (90 D): 254 Institutional Trades Total Inst.Trades: 440 Avg Inst. Trade: $1.33M Avg Inst. Trade (30 D): $.55M Avg Inst. Trade (90 D): $.55M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.54M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 9.72K     News Dec 31, 2024 @ 10:58 AM Antimicrobial Resistance Diagnostic Markets, Strat... Source: Researchandmarkets.Com Oct 25, 2024 @ 8:30 PM Accelerate Diagnostics Scheduled Call to Review 20... Source: Prnewswire Jul 22, 2024 @ 5:49 PM Antimicrobial Resistance Surveillance Market Size ... Source: Sns Insider May 8, 2024 @ 10:25 PM Accelerate Diagnostics (AXDX) Reports Q1 Loss, Mis... Source: Zacks Equity Research May 7, 2024 @ 9:30 PM Treace Medical Concepts (TMCI) Reports Q1 Loss, To... Source: Zacks Equity Research Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.59 $-.5 $-.74 Diluted EPS $-.5 $-.74 Revenue $ 2.98M $ 2.99M $ 2.92M Gross Profit $ .86M $ .68M $ .72M Net Income / Loss $ -14.64M $ -11.59M $ -14.23M Operating Income / Loss $ -8.62M $ -8.61M $ -10.16M Cost of Revenue $ 2.12M $ 2.31M $ 2.2M Net Cash Flow $ 11.1M $ -6.02M $ 2.47M PE Ratio     Splits Jul 12, 2023:   10:1